» Articles » PMID: 37520124

PINNet: a Deep Neural Network with Pathway Prior Knowledge for Alzheimer's Disease

Overview
Specialty Geriatrics
Date 2023 Jul 31
PMID 37520124
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Identification of Alzheimer's Disease (AD)-related transcriptomic signatures from blood is important for early diagnosis of the disease. Deep learning techniques are potent classifiers for AD diagnosis, but most have been unable to identify biomarkers because of their lack of interpretability.

Methods: To address these challenges, we propose a pathway information-based neural network (PINNet) to predict AD patients and analyze blood and brain transcriptomic signatures using an interpretable deep learning model. PINNet is a deep neural network (DNN) model with pathway prior knowledge from either the Gene Ontology or Kyoto Encyclopedia of Genes and Genomes databases. Then, a backpropagation-based model interpretation method was applied to reveal essential pathways and genes for predicting AD.

Results: The performance of PINNet was compared with a DNN model without a pathway. Performances of PINNet outperformed or were similar to those of DNN without a pathway using blood and brain gene expressions, respectively. Moreover, PINNet considers more AD-related genes as essential features than DNN without a pathway in the learning process. Pathway analysis of protein-protein interaction modules of highly contributed genes showed that AD-related genes in blood were enriched with cell migration, PI3K-Akt, MAPK signaling, and apoptosis in blood. The pathways enriched in the brain module included cell migration, PI3K-Akt, MAPK signaling, apoptosis, protein ubiquitination, and -cell activation.

Discussion: By integrating prior knowledge about pathways, PINNet can reveal essential pathways related to AD. The source codes are available at https://github.com/DMCB-GIST/PINNet.

Citing Articles

Explainable Machine Learning Models for Brain Diseases: Insights from a Systematic Review.

Rodriguez Mallma M, Zuloaga-Rotta L, Borja-Rosales R, Rodriguez Mallma J, Vilca-Aguilar M, Salas-Ojeda M Neurol Int. 2024; 16(6):1285-1307.

PMID: 39585057 PMC: 11587041. DOI: 10.3390/neurolint16060098.


Towards early diagnosis of Alzheimer's disease: advances in immune-related blood biomarkers and computational approaches.

Krix S, Wilczynski E, Falgas N, Sanchez-Valle R, Yoles E, Nevo U Front Immunol. 2024; 15():1343900.

PMID: 38720902 PMC: 11078023. DOI: 10.3389/fimmu.2024.1343900.

References
1.
Morgan B . Complement in the pathogenesis of Alzheimer's disease. Semin Immunopathol. 2017; 40(1):113-124. PMC: 5794825. DOI: 10.1007/s00281-017-0662-9. View

2.
Lee T, Lee H . Prediction of Alzheimer's disease using blood gene expression data. Sci Rep. 2020; 10(1):3485. PMC: 7044318. DOI: 10.1038/s41598-020-60595-1. View

3.
Kim Y, Liu G, Leugers C, Mueller J, Francis M, Hefti M . Tau interacts with SHP2 in neuronal systems and in Alzheimer's disease brains. J Cell Sci. 2019; 132(14). PMC: 6679582. DOI: 10.1242/jcs.229054. View

4.
Ashburner M, Ball C, Blake J, Botstein D, Butler H, Cherry J . Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000; 25(1):25-9. PMC: 3037419. DOI: 10.1038/75556. View

5.
Yiannopoulou K, Papageorgiou S . Current and Future Treatments in Alzheimer Disease: An Update. J Cent Nerv Syst Dis. 2020; 12:1179573520907397. PMC: 7050025. DOI: 10.1177/1179573520907397. View